z-logo
open-access-imgOpen Access
PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
Author(s) -
Abdelrahman Y. Sherif,
Gamaleldin I. Harisa,
Fars K. Alanazi,
Fahd A. Nasr,
Ali S. Alqahtani
Publication year - 2022
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s365974
Subject(s) - solid lipid nanoparticle , gefitinib , cytotoxicity , zeta potential , in vivo , pharmacology , ex vivo , medicine , chemistry , cancer , nanotechnology , in vitro , materials science , nanoparticle , biochemistry , biology , epidermal growth factor receptor , drug , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom